1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Behavioral Variant Frontotemporal Dementia (bvFTD): new trials by email Literature Review of Behavioral Variant Frontotemporal Dementia (bvFTD) trials Research Report on Behavioral Variant Frontotemporal Dementia (bvFTD)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD) TRx0237, Placebo - Behavioral Variant Frontotemporal Dementia (bvFTD) | Phase 3 | Completed | TauRx Therapeutics Ltd | 220 | 2013-05-01 | 2018-03-14 |
Brain Diseases (1) · Central Nervous System Diseases (1) · Dementia (1) · Frontotemporal Lobar Degeneration (1) · Mental Disorders (1) · Metabolic Diseases (1) · Nervous System Diseases (1) · Neurocognitive Disorders (1) · Neurodegenerative Diseases (1) · Nutritional and Metabolic Diseases (1) · Proteostasis Deficiencies (1) · TDP-43 Proteinopathies (1)
Australia (1) · Canada (1) · Croatia (1) · Germany (1) · Italy (1) · Netherlands (1) · Poland (1) · Romania (1) · Singapore (1) · Spain (1) · United Kingdom (1) · United States (1)